Osteosarcoma and Malignant Fibrous Histiocytoma of Bone PDQ®

In brief

NCI's evidence-based clinical reference for healthcare professionals treating osteosarcoma and malignant fibrous histiocytoma of bone. Covers diagnostic approaches, staging systems, treatment protocols including surgery and chemotherapy, and prognostic factors for these primary bone malignancies.

• Osteosarcoma and malignant fibrous histiocytoma (MFH) are primary bone malignancies requiring multimodal treatment approaches.
• PDQ® provides evidence-based, peer-reviewed treatment guidelines for health professionals managing these rare bone tumors.
• Treatment typically involves surgical resection combined with chemotherapy to improve survival outcomes.
• Early diagnosis and referral to specialized oncology centers improves prognosis for patients with bone sarcomas.

Written by the GCMD Library team from the guideline.